Diabetologist Dr Arora emphasises the importance of 6 tests every 6 months for maintaining health as they aid in early ...

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

The EMERALD trial investigators randomly assigned 478 patients with ER+, HER2- advanced breast cancer on a 1:1 basis to receive elacestrant or physician’s choice of standard therapy, which was defined ...

Imagine living with unexplained changes and health issues for nearly a decade, only to discover it's a rare disease that was, until recently, very difficult to treat and can affect nearly every aspect ...

MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights ...

Based on the DESTINY-Breast06 phase III trial results demonstrating statistically significant and clinically meaningful progression-free survival benefit in patients treated with Enhertu vs.

From the "pot-bellied" appearance to the flaws in the LDDST, Cushing's disease remains one of our most complex endocrine ...

Women with early-stage breast cancer may someday be able to skip radiation after a lumpectomy. The DEBRA trial is testing the ...

For people without diabetes, a normal fasting blood glucose is about 70–99 mg/dL; a two-hour post-meal (postprandial) value ...

Iodine might be small in quantity but it is important. The mineral fuels thyroid hormones that regulate metabolism, mood, and energy. Yet, despite fortified salt, deficiency still lingers, often ...

Over the past two decades there have been tremendous advancements in the understanding of both the prevalence and the ...